NM_000771.3:c.430C>T

HGVS Expressions

  • NG_008385.1:g.8633C>T
  • NM_000771.3:c.430C>T
  • NP_000762.2:p.Arg144Cys
  • NC_000010.11:g.94942290C>T
Back to search Result
Clinvar Clinical Significance

Drug Response, Likely Benign

CTGA Clinical Significance

Drug Response

Variant Type

Substitution

dbSNP

1799853

Clinvar

8409

Epidemiology in the Arab World

View Map
Subject IDCountry of OriginAllele CountAllele FrequencyCTGA Clinical Significance Condition(s)ReferenceRemarks
122700.G.1.3Lebanon24Drug ResponseCoumarin ResistanceDjaffar-Jureidini et al. 2011 24 Healthy subjects with risk of over-an...
122700.G.1.5Lebanon6Drug ResponseCoumarin ResistanceDjaffar-Jureidini et al. 2011 3 Healthy subjects with risk of over-ant...
122700.G.1.6Lebanon4Drug ResponseCoumarin ResistanceDjaffar-Jureidini et al. 2011 4 Healthy subjects with risk of over-ant...
122700.G.1.8Lebanon9Drug ResponseCoumarin ResistanceDjaffar-Jureidini et al. 2011 9 healthy subjects exhibiting risk allel...
122700.G.1.10Lebanon6Drug ResponseCoumarin ResistanceDjaffar-Jureidini et al. 2011 6 healthy subjects carrying 3 risk allel...
122700.G.1.12Lebanon4Drug ResponseCoumarin ResistanceDjaffar-Jureidini et al. 2011 2 healthy subjects carrying 3 risk allel...
122700.G.1.13Lebanon2Drug ResponseCoumarin ResistanceDjaffar-Jureidini et al. 2011 2 healthy individuals carrying 3 risk al...
122700.G.1.15Lebanon2Drug ResponseCoumarin ResistanceDjaffar-Jureidini et al. 2011 1 healthy individual carrying 4 risk all...
122700.G.1.16Lebanon1Drug ResponseCoumarin ResistanceDjaffar-Jureidini et al. 2011 1 healthy individual carrying 4 risk all...
122700.G.2.3Lebanon52Drug ResponseCoumarin ResistanceEsmerian et al. 2011 52 out of 231 total subjects
122700.G.2.5Lebanon10Drug ResponseCoumarin ResistanceEsmerian et al. 2011 5 out of 231 total subjects
122700.G.2.6Lebanon9Drug ResponseCoumarin ResistanceEsmerian et al. 2011 9 out of 231 total subjects Allele carr...
171050.G.1United Arab Emirates0.11Al-Mahayri et al. 2020 100 (52 females, 48 males) normal health...
© CAGS 2024. All rights reserved.